The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Alembic Pharmaceuticals has received final approval from the U.S. Food and Drug Administration (U.S. FDA) for its abbreviated new drug application for antifungal drug Efinaconazole Topical Solution, ...

BEDMINSTER, N.J., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Alembic Therapeutics is pleased to announce the U.S. availability of Pivya® (pivmecillinam) tablets, 185mg, an oral prescription antibiotic. Pivya ...

Vadodara: Commuters will now be able to travel between two parallel roads, easing congestion at Genda Circle during peak hours, after unrestricted traffic movement was allowed on the road connecting ...

Alembic Pharmaceuticals has received U.S. Food and Drug Administration final approval for its abbreviated new drug application for Carbidopa, Levodopa and Entacapone Tablets in different strengths.

Alembic Pharmaceuticals Limited (Alembic), a vertically integrated research and development pharmaceutical company, announced that it has received final approval from the US Food & Drug Administration ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Alembic Pharmaceuticals Limited (Alembic), a vertically integrated research and development pharmaceutical company, announced that it has received final approval from the US Food & Drug Administration ...

Alembic Pharmaceuticals Limited has announced that it has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Ticagrelor Tablets, 60 mg.

Aug 5 (Reuters) - India's Alembic Pharmaceuticals (ALEM.NS), opens new tab reported a 14.6% rise in consolidated profit for the first quarter on Tuesday, driven by strong sales in the U.S. and India.

Mumbai: Shares of Alembic Pharmaceuticals surged 13.61 percent on Monday after a major regulatory approval. The stock hit a high of Rs 1,104.10 during the day. The reason for this rise? Alembic got ...